8th Annual PEGS Europe
31 October 2016 - 04 November 2016
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Over the last three years, participation at PEGS Europe has grown by more than 60%, and this year will be the largest ever. With a more-focused technical program, and double the coverage of the most popular PEGS topics, the 2016 event will feature:
700 attendees
200 technical presentations
125 scientific posters
Dedicated networking opportunities
Exclusive exhibit & poster viewing hours
Interactive roundtable, breakout & panel discussions
EPIC SANA Lisboa Hotel, Lisbon, Portugal
http://www.pegsummiteurope.com/
World Precision Medicine Congress USA 2016
14 November 2016 - 15 November 2016
World Precision Medicine Congress USA 2016 will bring together big pharma, big data, and healthcare providers to discuss the scientific, economic, and policy goals towards producing precise and genomic-based medicines. With the launch of President Obama’s Precision Medicine Initiative (PMI) this year, this is a market segment that is primed for growth similar to what was seen in the Orphan Drug marketplace. The entire healthcare industry is beginning to shift towards medicines tailored to an individual’s genetic make-up, spurred on by better and cheaper diagnostics and gene sequencing technologies. By 2016, the precision medicine market is to be valued around $40 billion.
Hyatt Regency Washington on Capitol Hill, Washington DC, USA
http://www.terrapinn.com/conference/precision-medicine-congress-usa/index.stm?_ga=1.126178121.593631063.1465565274
Superbugs USA
14 November 2016 - 15 November 2016
Broadening horizons on the growing global threat of Antimicrobial resistance (AMR) for almost two decades at the sell-out Superbugs & Superdrugs conference in Europe, SMi is thrilled to announce the expansion of its antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA. This year’s show in Iselin, New Jersey, will play host to an audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to discuss the latest clinical advancements and funding opportunities.
With huge interest from leaders in the field including pending confirmations from PAHO/WHO, Astra Zeneca and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Superbugs & Superdrugs event to date.
The programme will hone in on key topics such as public private partnerships, collaboration, R&D, scientific priorities for antibiotic discovery, novel antibacterial therapeutic approaches, antibiotic stewardship, rapid diagnostic tools, combination therapies, resistance prevention, plus much more! Featured speakers include: BARDA, NIH, Janssen Research & Development LLC, Pfizer, Entasis Therapeutics and UNT Health Science Center. For further information visit http://www.superbugs-usa.com/ddtoday or contact Teri Arri on email: tarri@smi-online.co.uk, tel: +44 (0)20 7827 6162
Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
https://www.smi-online.co.uk/pharmaceuticals/northamerica/superbugs-superdrugs-usa?utm_medium=www.superbugs-usa.com&utm_source=P-193&utm_campaign=ddtoday
European Antibody Congress 2016
14 November 2016 - 16 November 2016
Develop your production by learning about innovative new platforms and technologies
Hear industry leader’s views on the clinical and commercial future of antibodies and how this might affect your business.
Learn about the latest discoveries and developments in the production of new antibody drugs.
Network with the real pioneers, thought leaders and influencers
Congress Center Basel, Basel, Switzerland
http://www.terrapinn.com/conference/european-antibody-congress/index.stm
Biosimilars North America
16 November 2016 - 17 November 2016
Building on previous success, SMi proudly announces the return of 3rd Annual Biosimilars North America conference to New Jersey in November 2016!
This meeting will update you with the latest market developments and regulatory updates to ensure you stay at the forefront of this evolving market!
Join us today to:
•Hear latest regulatory updates for smooth and speedy approval
•Learn successful biosimilar case studies to reshape your business model
•Dissect regional market growth opportunities - where should you go next?
•Network with like-minded senior experts and engage in interactive debates
Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
https://www.smi-online.co.uk/pharmaceuticals/northamerica/biosimilars-north-america?utm_medium=www.biosimilars-northamerica.com&utm_source=P-189&utm_campaign=ddt
Biotech and Money New York 2016
21 November 2016 - 21 November 2016
Biotech and Money New York 2016 aims to provide genuine peer 2 peer knowledge sharing, networking and deal making opportunities between CxO level executives, and uncover new ideas to move the industry forward. At its heart is a mission to promote NYC and the region as a center for life science excellence and help build linkages and business opportunities between East Coast life science companies and capital.
The key themes include: academic translation and commercialization, early stage venture / corporate venture, build to buy and virtual biotech models, industry alliances, growth and late stage venture capital, venture philanthropy and non-traditional finance, private and public financing, M&A and strategic transactions.
Convene Midtown East, 730 Third Avenue 17th Floor, New York, NY 10017, USA
https://www.eventbrite.co.uk/e/2nd-annual-biotech-and-money-new-york-2016-tickets-26050024324?aff=ebapi